Atlas Trials

Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program

Clinical trial NCT07022379 · COMPLETED

Trial details

NCT number
NCT07022379
Sponsor
Satelia
Status
COMPLETED
Study type
OBSERVATIONAL
Heart FailureHeart Failure With Preserved Ejection Fraction (HFPEF)Heart Failure With Reduced Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Start date
2021-01-01
Primary completion
2024-12-31
Enrollment
13660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.